Use the Search Fields to Find Information
Page 141 of 375
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Abstract We conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in subjects, the majority of whom were experiencing neuropathic pain
October 3, 2024
Low-dose metoclopramide-induced dystonia in cannabis withdrawal syndrome manifesting as intractable nausea and vomiting
Please use this link to access this publication. Abstract Cannabis withdrawal syndrome (CWS) presents with irritability, anxiety and sleep disturbances within a week of stopping
February 15, 2026
Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
Abstract Studies on the effective and safe therapeutic dosage of delta-9-tetrahydrocannabinol (THC) for the treatment of Alzheimer’s disease (AD) have been sparse due to the
February 15, 2024
Low doses of cannabis extract ameliorate non-motor symptoms of Parkinson’s disease patients: a case series
Abstract Introduction: Parkinson’s disease (PD) is mainly characterized by motor symptoms including muscle rigidity, resting tremor and bradykinesia. However, the management of the non-motor symptoms represent
May 1, 2025
Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
Abstract There are two well-characterized cannabinoid receptors (CB1R and CB2R and other candidates): the central nervous system (CNS) enriched CB1R and peripheral tissue enriched CB2R
September 19, 2025
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Although endocannabinoid signaling is important for certain aspects of gastrointestinal homeostasis, the role of the cannabinoid receptors (CB) in colorectal cancer has not been defined.
September 19, 2019
Looking beyond traditional pain outcomes to better evaluate cannabis’s true potential and limitations in chronic pain management.
Abstract Cannabis is increasingly used for managing chronic pain, despite the low quality and inconsistency of most evidence from randomized controlled trials and the divergent
January 18, 2026
Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy
Please use this link to access this publication. Abstract Objective To assess the longitudinal impact of highly purified cannabidiol (CBD) on the electroencephalogram (EEG) of
April 19, 2024
Longitudinal associations of cannabis, depression, and anxiety in heterosexual and LGB adolescents.
Please use this link to access this publication. Abstract Cannabis use is linked to symptoms of depression and anxiety, particularly among sexual minorities. This study
June 20, 2025
Longitudinal associations between insomnia, cannabis use and stress among US veterans
Summary Insomnia is highly prevalent among military veterans, with rates nearly double that of civilian populations. Insomnia typically co-occurs with other psychological problems, including substance
December 17, 2024
Page 141 of 375